ABVX:NASDAQ
Abivax SA
US$98.50
arrow_upward
+1.70%(+1.65) 1 天
US$98.36
arrow_downward
-0.14% (-0.14)today开盘前
休市： 9月29日, GMT-4 16:00:01 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 ABVX 生成关键数据洞见…
开盘价
US$96.97
最高价
US$99.17
最低价
US$94.40
市值
75.91亿
平均成交量
120.70万
成交量
937.00
52 周最高价
US$148.83
52 周最低价
US$69.81
流通股数
8735.00万
员工人数
98
开盘价
US$96.97
最高价
US$99.17
最低价
US$94.40
市值
75.91亿
平均成交量
120.70万
成交量
937.00
52 周最高价
US$148.83
52 周最低价
US$69.81
流通股数
8735.00万
员工人数
98
新闻报道
来自网络来源和新闻合作伙伴
Benzinga
·
15小时前
10 Health Care Stocks Whale Activity In Today’s Session
Ideal Investisseur
·
23小时前
Abivax stock among the most sought-after SBF 120 values despite −12.5% over one month
Timothy Sykes
·
1天前
ABVX Stock Draws Bullish Targets As Obefazimod Momentum Builds
Timothy Sykes
·
1天前
ABVX Stock Gains Traction As Obefazimod Story Strengthens
资料
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Abivax SA简介